Diallo, Alpha

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,662

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,229

TREOCAPA: prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen—statistical analysis plan for the randomized phase III group sequential trial

Ursino, M., Alberti, C., Cambonie, G., Kemp, R., Vanhecke, A., Levoyer, L., Diallo, A., Hallman, M., Rozé, J.-C., for the TREOCAPA study group, et al. (2025) · Trials

Cardiovascular Conditions and TreatmentsPharmaceutical studies and practices

Cited by 8

TREOCAPA: Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen. Statistical analysis plan for the randomized phase III group sequential trial

Ursino, M., Alberti, C., Cambonie, G., Kemp, R., Vanhecke, A., Levoyer, L., Diallo, A., Hallman, M., & Rozé, J.-C. C. (2024) · Trials

Cardiovascular Conditions and TreatmentsPharmaceutical studies and practices

Cited by 8